HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools
00
Days
00
Hours
00
Mins
00
Sec
Register Now!
Market News Stocks News ETF News Crypto News

Olema Oncology

Contributing Author

Recent Articles by Olema Oncology

Nov-21
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference OLMA GlobeNewswire
Nov-20
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares OLMA GlobeNewswire
Nov-19
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock OLMA GlobeNewswire
Nov-18
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants OLMA GlobeNewswire
Nov-10
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results OLMA GlobeNewswire
Nov-04
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Nov-03
Olema Oncology to Participate in Upcoming Investor Conferences OLMA GlobeNewswire
Oct-30
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025 OLMA GlobeNewswire
Oct-18
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025 OLMA GlobeNewswire
Oct-02
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Sep-03
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Sep-02
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer OLMA GlobeNewswire
Aug-20
Olema Oncology to Participate in Upcoming Investor Conferences OLMA GlobeNewswire
Aug-11
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results OLMA GlobeNewswire
Aug-04
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Jul-02
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Jun-03
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
May-28
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting OLMA GlobeNewswire
May-21
Olema Oncology to Participate in Upcoming Investor Conferences OLMA GlobeNewswire
May-13
Olema Oncology Reports First Quarter 2025 Financial and Operating Results OLMA GlobeNewswire
May-09
Olema Oncology to Participate in Upcoming Investor Conferences OLMA GlobeNewswire
May-02
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) OLMA GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.